Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France

OBJECTIVES: To estimate the frequency of reporting composite indices evaluating axial spondyloarthritis (axSpA) disease activity in daily practice and to assess its impact on the secukinumab (SEC) retention rate. METHODS: Study design: Retrospective, multicentre. Data collected: (1) Recommended comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougados, Maxime, Lucas, Julien, Desfleurs, Emilie, Lukas, Cédric, Saraux, Alain, Tournadre, Anne, Ruyssen-Witrand, Adeline, Wendling, Daniel, Goupille, Philippe, Claudepierre, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932274/
https://www.ncbi.nlm.nih.gov/pubmed/35301266
http://dx.doi.org/10.1136/rmdopen-2021-002106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932274/
https://www.ncbi.nlm.nih.gov/pubmed/35301266
http://dx.doi.org/10.1136/rmdopen-2021-002106

Ejemplares similares